Black physicians are excited about a groundbreaking gene-editing treatment for sickle cell disease that a federal advisory panel deemed safe enough for clinical use this week — but they also worry about access. “It offers a lot of potential,” Dr. Oyebimpe Adesina, a hematologist at the University of California Davis, told Capital B Tuesday. “But […]